Drug Use Investigation of Fosrenol for Hyperphosphatemia With Chronic Kidney Disease Not on Dialysis
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Lanthanum carbonate (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 07 Dec 2016 Status changed from active, no longer recruiting to completed.
- 21 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 26 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Oct 2016.